The terms of use also disclose the inherent limitation of this model directly: a provider working asynchronously "may not have the benefit of information that would be obtained by examining you in person," and the diagnosis you receive may be "limited and, in some cases, provisional." Buyer takeaway: if you have a complex medical history, be thorough in your intake
Starting July 2026, a short-term program called the Medicare GLP-1 Bridge, designed as a bridge to the broader BALANCE model, will cover Wegovy, Zepbound and Foundayo for eligible Part D enrollees at a $50 monthly copayment
Semaglutide therapy can trigger fatigue during the first weeks of treatment, especially as your dose increases
when the body has less available bile acid, it turns to LDL cholesterol as a replacement, effectively pulling LDL out of circulation and lowering it